Cargando…
A SMAD4‐modulated gene profile predicts disease‐free survival in stage II and III colorectal cancer
BACKGROUND: Colorectal cancer is the second‐leading cause of cancer‐related mortality in the United States and a leading cause of cancer‐related mortality worldwide. Loss of SMAD4, a critical tumor suppressor and the central node of the transforming growth factor‐beta superfamily, is associated with...
Autores principales: | Szeglin, Bryan C., Wu, Chao, Marco, Michael R., Park, Hyun Sung, Zhang, Zeda, Zhang, Bing, Garcia‐Aguilar, Julio, Beauchamp, R. Daniel, Chen, X. Steven, Smith, J. Joshua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789617/ https://www.ncbi.nlm.nih.gov/pubmed/34114372 http://dx.doi.org/10.1002/cnr2.1423 |
Ejemplares similares
-
Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020) -
Microsatellite instability & survival in patients with stage II/III colorectal carcinoma
por: Srdjan, Markovic, et al.
Publicado: (2016) -
Vitamin D Status and Survival in Stage II-III Colorectal Cancer
por: Bao, Yichao, et al.
Publicado: (2020) -
Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients
por: Alkader, Mohammad S, et al.
Publicado: (2023) -
Predictors of recurrence free survival for patients with stage II and III colon cancer
por: Tsikitis, Vassiliki L, et al.
Publicado: (2014)